You are here: Industry Insights > Novavax

News List

Novavax files for Conditional Marketing Authorisation of COVID-19 vaccine in Switzerland ExpressPharma
February 15, 2022
The submission for the regulatory evaluation of the vaccine includes data from two phase-III clinical trials.
Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine prnasia
February 15, 2022
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Singapore Health Sciences Authority...
Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial prnasia
February 14, 2022
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that NVX-CoV2373...
Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain* prnasia
February 07, 2022
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and Healthcare products Regulatory Agency...
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine prnasia
February 07, 2022
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases...
Novavax gets New Zealand’s provisional approval for Covid-19 vaccine Pharmaceutical-Technology
February 07, 2022
New Zealand’s Medsafe has granted provisional approval for Novavax’s adjuvanted Covid-19 vaccine, NVX-CoV2373, for active immunisation to prevent Covid-19 in individuals aged 18 years and above.
Novavax seeks EUA from FDA for Covid-19 vaccine pharmaceutical-business-review
February 01, 2022
Novavax has submitted a request seeking emergency use authorisation (EUA) from the US Food and Drug Administration...
Novavax Covid-19 vaccine to be rolled out in Australia from next month Pharmaceutical-Technology
January 26, 2022
Australia’s health minister said Novavax’s coronavirus jab, Nuvaxovid, should be available from February 21.
Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine prnasia
January 20, 2022
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Australia's Therapeutic Goods Administration...
South Korea grants approval to Novavax Covid-19 vaccine Pharmaceutical-Technology
January 13, 2022
SK bioscience will handle the manufacturing and commercialisation of the vaccine in South Korea.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page